Critical COVID-19

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-06-21
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 [Phase 2]
Phase 2 trial evaluating the efficacy and safety of sirukumab in adults with severe or critical COVID-19 has completed with posted results.